Roger Jeffs
Director; Director, Chief Executive Officer · 16 filings · Latest: Oct 9, 2026
Axsome Therapeutics, Inc.
Liquidia Corp
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
LQDA | SERENDIPITY BIOPHARMA LLC | — | Apr 10, 2026 | Proposed Sale | $40.32 | 25,000 | $1.0M | — | |
LQDA | SERENDIPITY BIOPHARMA LLC | — | Apr 9, 2026 | Proposed Sale | $38.19 | 25,000 | $954.8K | — | |
AXSM | JEFFS ROGER | — | Sep 2, 2025 | Proposed Sale | $123.68 | 13,464 | $1.7M | — | |
AXSM | JEFFS ROGER | — | Aug 29, 2025 | Proposed Sale | $121.27 | 20,000 | $2.4M | — | |
AXSM | JEFFS ROGER | — | Aug 28, 2025 | Proposed Sale | $121.60 | 20,000 | $2.4M | — | |
AXSM | JEFFS ROGER | — | Aug 27, 2025 | Proposed Sale | $122.30 | 20,000 | $2.4M | — | |
AXSM | JEFFS ROGER | — | Aug 26, 2025 | Proposed Sale | $120.03 | 20,000 | $2.4M | — | |
AXSM | JEFFS ROGER | — | Aug 22, 2025 | Proposed Sale | $120.08 | 16,694 | $2.0M | — |
← Previous
Page 3 of 3